Seth Frank - Evolent Health VP Relations

9EH Stock  EUR 10.70  0.40  3.88%   

Insider

Seth Frank is VP Relations of Evolent Health
Phone571 389 6000
Webhttps://www.evolenthealth.com

Evolent Health Management Efficiency

Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
Evolent Health has accumulated 215.68 M in total debt with debt to equity ratio (D/E) of 24.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evolent Health has a current ratio of 1.92, which is within standard range for the sector. Debt can assist Evolent Health until it has trouble settling it off, either with new capital or with free cash flow. So, Evolent Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evolent Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evolent to invest in growth at high rates of return. When we think about Evolent Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Claudia ThomCompugroup Medical SE
52
Brad BennionHealthequity
N/A
Benjamin Hindson10X GENOMICS DL
44
Claus JensenTeladoc
N/A
Tyson MurdockHealthequity
52
Mike WatersTeladoc
N/A
Jean Philibert10X GENOMICS DL
59
Pinal PatelVeeva Systems
N/A
Mathai Mammen10X GENOMICS DL
51
Ato GarrettVeeva Systems
N/A
Steve LindsayHealthequity
N/A
Christopher BischoffTeladoc
46
Cheng LiuPing An Healthcare
48
Michael FranzCompugroup Medical SE
N/A
George BrooksTeladoc
N/A
Hannes ReichlCompugroup Medical SE
47
Sridhar Kosaraju10X GENOMICS DL
41
Andrew TuritzTeladoc
50
Eric Whitaker10X GENOMICS DL
52
Glen TullmanTeladoc
N/A
Richard NapolitanoTeladoc
56
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people. Evolent Health (9EH) is traded on Frankfurt Exchange in Germany and employs 4,000 people.

Management Performance

Evolent Health Leadership Team

Elected by the shareholders, the Evolent Health's board of directors comprises two types of representatives: Evolent Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolent. The board's role is to monitor Evolent Health's management team and ensure that shareholders' interests are well served. Evolent Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolent Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan JD, Gen Officer
Aammaad Shams, Chief Controller
Jessica Somers, Sr Devel
Seth Frank, VP Relations
MAAA FSA, Chief Officer
John Johnson, Chief Officer
Seth Blackley, CEO CoFounder
Frank Williams, CoFounder Chairman
Kali Beyah, Chief Officer
Dan McCarthy, CEO Pres

Evolent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evolent Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Evolent Stock

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.